Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Patrick Machado

Pharmaceutical Science
United States of America


 Mr. Machado joined our board in September 2015. Mr. Machado is a co-founder of Medivation, Inc., a biopharmaceutical company that was acquired by Pfizer, Inc. in 2016. Prior to his retirement in April 2014, Mr. Machado served as Medivation’s Chief Financial Officer since its inception in September 2003 and as its Chief Business Officer since December 2009. From 1998 until 2001, Mr. Machado was employed by ProDuct Health, Inc., a privately held medical device company, as Vice President, Chief Financial Officer and General Counsel (1998-2000) and as Senior Vice President and Chief Financial Officer (2000-2001). From 2001 until 2002, Mr. Machado served as a consultant to Cytyc Corporation (NASDAQ:CYTC) to assist with transitional matters related to Cytyc Corporation’s acquisition of ProDuct Health, Inc. Mr. Machado currently serves on the board of directors of biopharmaceutical companies Adverum Biotechnologies, Inc. (NASDAQ:ADVM), Chimerix, Inc. (NASDAQ:CMRX), Inotek Pharmaceuticals (NASDAQ:ITEK), Roivant Sciences Ltd. and Armaron Bio Pty. Ltd., where he also serves as chair of the board. Mr. Machado received a J.D. from Harvard Law School and a B.A. and B.S. in German and Economics, respectively, from Santa Clara University.

Research Interest

 Pharmaceutical Science

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences